Narayana Hrudaya

Narayana Hrudaya's India business demonstrated strong performance in Q3 FY26, achieving very high profit growth for the second consecutive quarter. This was accompanied by a significant margin expansion of almost 150-200 basis points on a year-on-year basis. The Bangalore cluster was a key driver, benefiting from payor mix optimization initiatives and increased volumes of high-end robotic cardiac surgeries and other advanced procedures, leading to improved realizations and revenue. The company plans to replicate this successful template across other clusters, including the eastern cluster, and address soft growth in the northern cluster by active marketing and optimization strategies over the short term.

The Cayman Islands operations reported hospital revenue of $45 million. However, the Cayman insurance business experienced widening losses sequentially, prompting a shift in focus from aggressive expansion to optimizing the existing book through improved underwriting and operational processes. In the UK, the acquired Practice Plus business recorded an EBITDA margin of 8.5-9% (pre-IFRS) or 12% (post-IFRS), with a slight moderation in Q3. Management acknowledges that UK profitability will not match Cayman due to differing market profiles but aims to improve margins by implementing its technology platform and operational efficiencies on a larger scale. The Birmingham unit is targeted to break even within four quarters, with half that period already elapsed.

The company's planned capital expenditure for FY26 is approximately INR 3000 crore, to be funded through a mix of internal accruals and debt. This capex includes investments in four Davinci robots to equip all hospitals for robotic surgery and expansion of oncology services. For the UK acquisition, GBP 150 million in debt and GBP 45 million in equity were deployed, with the debt having a 2+5 year repayment schedule. The company aims to maintain its consolidated net debt to EBITDA ratio below 2.5, indicating a prudent approach to leverage.

Narayana Hrudaya's long-term vision is to build a world-class healthcare institution providing accessible and affordable care. The strategy involves consolidating presence in core markets like Bangalore and Delhi, and growing in other successful markets such as Raipur, Ahmedabad, Jaipur, and Mumbai through a combination of hospitals, clinics, and insurers. The company aims for a significant presence in its core markets, ensuring an NH Centre (hospital or clinic) is within 25 minutes' reach. Oncology and cardiac services are expected to collectively account for over half of future revenue, with oncology potentially growing by another 20%.

The company's insurance business has seen increasing acceptance and productivity, expanding its retail offerings beyond Bangalore to Kolkata, Raipur, and Mysore. It has also entered the SME market, providing integrated care solutions that include outpatient care, consultation, and medicines, in addition to hospitalization. While the insurance business is currently in a building stage and profitability is not yet substantial, management is optimistic about future growth, viewing the integrated approach as unique and resonant with the market.

A key focus for Narayana Hrudaya is improving in-hospital efficiencies through operational expertise, streamlining, cost cutting, and digitization. This approach aims to deliver world-class clinical service at competitive prices without compromising quality. The company is also leveraging technology, such as high-end robotic work, to enhance margins and realizations. The implementation of its technology platform and operational efficiencies, successfully applied in Cayman, is now being scaled to the UK operations to drive margin improvement there.